Back to News
Market Impact: 0.44

Alnylam Q1 Earnings Beat Estimates, Amvuttra Sales Drive Y/Y Growth

ALNY
Corporate EarningsCompany FundamentalsHealthcare & BiotechAnalyst Estimates

ALNY beat Q1 earnings and revenue estimates as Amvuttra sales surged 187%, driving 96% revenue growth. Strong product momentum more than offset declines in collaborator revenue and Onpattro sales, pointing to improving core fundamentals. The print should be supportive for the stock, though the impact is primarily company-specific rather than sector-wide.

Analysis

ALNY beat Q1 earnings and revenue estimates as Amvuttra sales surged 187%, driving 96% revenue growth. Strong product momentum more than offset declines in collaborator revenue and Onpattro sales, pointing to improving core fundamentals. The print should be supportive for the stock, though the impact is primarily company-specific rather than sector-wide.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.72

Ticker Sentiment

ALNY0.84